RT @angusgjones: Q: What should you do when HbA1c has not improved with a new glucose lowering therapy: add, switch, or continue? Answer: A…
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
2型糖尿病患者のHbA1cが未改善(増加や僅かな減少)の場合において、薬剤の変更は継続より僅かにHbA1cを減少させ、薬剤の追加は大幅に減少させた。 https://t.co/tInthdg6VP
RT @PenCLAHRC: New @UniofExeter research informs best outcome on type 2 diabetes treatment. Read the story here: https://t.co/ISRpAp6IyX &…
RT @PenCLAHRC: New @UniofExeter research informs best outcome on type 2 diabetes treatment. Read the story here: https://t.co/ISRpAp6IyX &…
New @UniofExeter research informs best outcome on type 2 diabetes treatment. Read the story here: https://t.co/ISRpAp6IyX & the @BMCMedicine paper here: https://t.co/CaqX2BCjZP #exeterdiabetes #diabetes @ExeterMed @OfficialNIHR https://t.co/MwCZKORaCL
RT @UEMSHealthStats: What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? https://t.co/BQ22YLQ7k…
What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? https://t.co/BQ22YLQ7k9 #healthstats #healthstatistics #ExeterDiabetes @ExeterMed @UofE_Research @bshieldsexeter @john_den_ @BioMedCentral
RT @Office_j: 【血糖管理不良時の薬剤「変更」は適切?/ BMC Med】 英国GPデータベース、HbA1c「>7.5」%への血糖低下薬6カ月で「≧0.5%」低下しなかった2型DM 12168例:薬剤「変更」群と「継続」群間で、12カ月後のHbA1c変化幅に有意差…
RT @Office_j: 【血糖管理不良時の薬剤「変更」は適切?/ BMC Med】 英国GPデータベース、HbA1c「>7.5」%への血糖低下薬6カ月で「≧0.5%」低下しなかった2型DM 12168例:薬剤「変更」群と「継続」群間で、12カ月後のHbA1c変化幅に有意差…
RT @Office_j: 【血糖管理不良時の薬剤「変更」は適切?/ BMC Med】 英国GPデータベース、HbA1c「>7.5」%への血糖低下薬6カ月で「≧0.5%」低下しなかった2型DM 12168例:薬剤「変更」群と「継続」群間で、12カ月後のHbA1c変化幅に有意差…
RT @docwas: Interesting paper tackling the dilemma of Switch or continue....would have been more interesting to see for second line agents…
【血糖管理不良時の薬剤「変更」は適切?/ BMC Med】 英国GPデータベース、HbA1c「>7.5」%への血糖低下薬6カ月で「≧0.5%」低下しなかった2型DM 12168例:薬剤「変更」群と「継続」群間で、12カ月後のHbA1c変化幅に有意差なし。傾向スコアマッチ比較でも同様。 https://t.co/tETwFqr5Jm [Free] https://t.co/wN3eEq7a4a
What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study. https://t.co/6FwJfN5MnP
Great review in #Mastermind but why only non-insulin therapies? When patients with #diabetes aren't achieving targets, clinical inertia in delaying #Insulin isn't doing anybody any favours
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
What to do with #diabetes therapies when #HbA1c lowering is inadequate: Add, switch, or continue? #MASTERMIND study (outcomes of 55,530 patients with T2DM) recommendations Bu care to be more than just medications https://t.co/dfFvnCsGvu
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
Interesting paper tackling the dilemma of Switch or continue....would have been more interesting to see for second line agents @kamleshkhunti @AmarPut @AbdTahrani @drpatrickholmes @sribellary @Nirantharakumar @drnkan
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
#T2DM add/switch/continue? @ABCDiab @DiabetesUK @JohnGrumitt @AmarPut @Paddy_English @Roxytonin @sama_wilkinson @drpatrickholmes
RT @angusgjones: Q: What should you do when HbA1c has not improved with a new glucose lowering therapy: add, switch, or continue? Answer: A…
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
RT @angusgjones: Q: What should you do when HbA1c has not improved with a new glucose lowering therapy: add, switch, or continue? Answer: A…
RT @angusgjones: Q: What should you do when HbA1c has not improved with a new glucose lowering therapy: add, switch, or continue? Answer: A…
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
RT @angusgjones: Q: What should you do when HbA1c has not improved with a new glucose lowering therapy: add, switch, or continue? Answer: A…
RT @angusgjones: Q: What should you do when HbA1c has not improved with a new glucose lowering therapy: add, switch, or continue? Answer: A…
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
RT @athattersley: Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For bes…
Add, switch, or continue if the HbA1c rises 6 months after starting a new treatment? An everyday dilemma in T2D. For best control ADD easily beats SWITCH! Grt analysis of routine clinical data @andymcgovern3 & @angusgjones #exeterdiabetes https:/
New research article: What to do with #diabetes #therapies when HbA1c lowering is inadequate: add, switch, or continue? A #MASTERMIND study https://t.co/Z9CtQndtm1 @ExeterMed @UoDMedicine https://t.co/AjNCvYrNoY
Q: What should you do when HbA1c has not improved with a new glucose lowering therapy: add, switch, or continue? Answer: Add additional therapy. Switching therapy does not meaningfully improve glycaemic control. https://t.co/3uCfp9N2Ka #ExeterDiabetes #T2